NIEHS Worker Training Program’s SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
ID: 358912Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the NIEHS Worker Training Program for small businesses to develop Technology-Enhanced Training Products aimed at improving health and safety training for hazardous materials (HAZMAT) workers and emergency responders. This initiative seeks applications for the SBIR E-Learning for HAZMAT and Emergency Response (R43/R44), focusing on innovative training solutions such as online courses, augmented reality, and serious gaming to enhance the training experience. The program is crucial for equipping workers with the necessary skills to protect themselves and their communities from hazardous materials exposure, with an estimated total funding of $688,000 available for approximately six awards. Interested applicants can reach out to Sharon D. Beard at NIEHS via email at beard1@niehs.nih.gov or by phone at 984-287-3237, with applications due by November 20, 2025, and anticipated awards announced by June 1, 2026.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    NIEHS Worker Training Program’s HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIEHS Worker Training Program for HAZMAT training at the Department of Energy's Nuclear Weapons Complex. This initiative aims to provide training and education to workers involved in hazardous waste management and emergency response, focusing on preventing work-related harm and promoting health and safety in the workforce. The program is funded under the Superfund Amendments and Reauthorization Act of 1986 and is expected to allocate approximately $3 million across two awards. Interested applicants, specifically private institutions of higher education, should note that the application period opens with a synopsis expected on September 24, 2025, and closes on November 25, 2025. For further inquiries, contact Sharon D. Beard at 984-287-3237 or via email at beard1@niehs.nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NIEHS Worker Training Program’s Hazardous Materials Worker Health and Safety Training (U45 – Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the NIEHS Worker Training Program's Hazardous Materials Worker Health and Safety Training (U45), which will not allow clinical trials. This funding opportunity aims to support the development of health and safety training for workers involved in hazardous materials activities, including generation, removal, containment, and emergency response, as authorized by the Superfund Amendments and Reauthorization Act of 1986. The program will focus on three areas: the Hazardous Waste Worker Training Program (HWWTP), the Environmental Career Worker Training Program (ECWTP), and the Hazmat Disaster Preparedness Training Program (HDPTP), with an estimated total funding of $6 million to support approximately five awards. Interested applicants, particularly those with expertise in occupational health and safety education, are encouraged to reach out to Sharon Beard at 984-287-3237 or via email at beard1@niehs.nih.gov, with applications expected to be submitted by November 25, 2025, and awards anticipated by June 1, 2026.
    Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) 
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant opportunity titled "Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)" aimed at accredited institutions of higher education. This program seeks to support research and training related to hazardous substances, with a focus on addressing environmental health issues, and encourages collaboration with various organizations, including universities, hospitals, and state and local governments. The estimated total funding for this program is $22 million, with approximately 10 awards expected to be made, and interested applicants can reach out to Dr. Danielle Carlin at danielle.carlin@nih.gov or by phone at 984-287-3244 for further information. Key deadlines include an estimated synopsis close date of March 12, 2026, and an anticipated award date of May 1, 2027.
    Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Promoting a Basic Understanding of Chemical Threats to Skin," aimed at small businesses interested in researching the pathological mechanisms of skin injuries caused by toxic chemicals. The initiative seeks to elucidate the commonalities in the mechanisms of skin injuries from various vesicants, such as sulfur mustard and Lewisite, with the goal of identifying shared therapeutic targets and developing broad-spectrum medical countermeasures for mass casualty events. The estimated total program funding is $2,500,000, with approximately five awards expected, and interested applicants are encouraged to collaborate and prepare their proposals ahead of the anticipated application period, which is expected to open in early 2026. For further inquiries, potential applicants can contact Dr. Peter J. Koch at Peter.Koch@NIH.gov or by phone at 240-987-8325.
    Research Education Projects
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Research Education Projects" aimed at supporting research education activities within its mission areas. This program, designated as R25, seeks to enhance training opportunities and prepare a skilled workforce to address the nation's biomedical, behavioral, and clinical research needs, while also promoting recruitment into research careers in these fields. The grant is available to small businesses, with no cost-sharing or matching requirements, and is categorized under discretionary funding with a CFDA number of 93.077. Interested applicants can reach out to the Division of Biomedical Research Workforce at NIH via email at NIHTrain@mail.nih.gov or by phone at 301-451-0993 for further information. Key deadlines include an estimated synopsis close date of May 25, 2026, and an estimated award date of February 1, 2027.
    Leveraging Nursing Research to Advance Healthy School Environments for All
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Leveraging Nursing Research to Advance Healthy School Environments for All," aimed at soliciting research applications that address the complex interactions between school environments, health services, and educational outcomes. This initiative seeks to promote multi-disciplinary and multisectoral research to fill critical gaps in understanding how these factors influence the health and educational success of youth. The grant is open to small businesses, with no cost-sharing or matching requirements, and is categorized under health funding activities. Interested applicants should note that the estimated synopsis post date is January 27, 2026, with a closing date of April 27, 2026, and the anticipated award date is September 1, 2026. For further inquiries, applicants can contact Bill Duval, PhD, at bill.duval@nih.gov or by phone at 301-435-0380.
    NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for small business concerns (SBCs) through the NINDS Exploratory Clinical Trials program (R43/R44), aimed at supporting investigator-initiated exploratory clinical trials related to neurological disorders. This program invites applications for studies that evaluate drugs, biologics, devices, or therapies, generating preliminary data to inform future clinical development, with a focus on enhancing diverse perspectives within research teams. Eligible U.S.-based SBCs can apply for funding caps of up to $295,924 for Phase I and $1,972,828 for Phase II, with applications due by September 5, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-311.html.
    Occupational Safety and Health Education and Research Centers (T42)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting grant applications for the Occupational Safety and Health Education and Research Centers (T42) program, aimed at enhancing occupational safety and health training. This initiative seeks to ensure a sufficient supply of qualified personnel to fulfill the mandates of the Occupational Safety and Health Act, with a focus on interdisciplinary training, research, and outreach in key disciplines such as industrial hygiene and occupational health nursing. With an estimated total program funding of $32 million, the CDC plans to award up to 18 grants, each ranging from $4.5 million to $9 million over a duration of 3 to 5 years. Interested applicants must submit their proposals electronically by October 26, 2028, and can direct inquiries to Dr. Elizabeth H. Maples at lbrowning@cdc.gov or by phone at 404-498-5014.
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.
    Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs," aimed at advancing research on the impact of Artificial Intelligence (AI) technologies on developmental outcomes in children at risk for specific learning disabilities. This initiative, led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), seeks small businesses to establish Centers that will explore innovative and high-risk research topics related to learning disabilities in reading, writing, and mathematics. The grant does not require cost-sharing or matching and is categorized under health funding activities, with an estimated award date of December 1, 2026. Interested applicants can reach out to Dr. Virginia Salo at virginia.salo@nih.gov or call 301-402-3682 for further information, with proposals due by June 4, 2026.